CARDIOSCALE CVRI
LIVE

Serial Number

79263328

Owner

CARDIO SCALE LTD

Attorney

Kevin D. McCarthy

Filing Date

Jan 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CARDIOSCALE CVRI Trademark

Serial Number: 79263328 • Registration: 6071838

CARDIOSCALE CVRI is a trademark filed by CARDIO SCALE LTD on January 28, 2019. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CARDIO SCALE LTD

45 Yam Hamelach St.

Entity Type: 99

Trademark Details

Filing Date

January 28, 2019

Registration Date

June 9, 2020

Published for Opposition

March 24, 2020

Goods & Services

Cardiovascular diagnostic services, namely, cardiovascular testing for diagnostic purposes

Medical instruments for cardiovascular diagnostic purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 9, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 2, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 2, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 9, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2020 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 14, 2019 RFCS
REFUSAL PROCESSED BY MPU
Aug 14, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 26, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 25, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 24, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 18, 2019 REPR